Surgical salvage of chemorefractory germ cell tumors

Brian R. Murphy, Elyse S. Breeden, John P. Donohue, Jon Messemer, William Walsh, Bruce J. Roth, Lawrence Einhorn

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

Purpose: Patients with disseminated germ cell tumors who relapse after salvage chemotherapy, or who progress during cisplatin-based therapy, have chemorefractory disease and a very poor prognosis. A subset of these patients will have chemorefractory but resectable disease. We have therefore evaluated the role of salvage surgery in this patient population. Patients and Methods: We performed a retrospective review of all patients with disseminated germ cell tumors who were felt to have chemorefractory disease and underwent salvage surgery from 1977 to 1990 at Indiana University. All patients had elevated serum markers or other signs of progressive carcinoma. A total of 48 patients underwent surgery (33 retroperitoneal lymph node dissections [RPLNDs], six thoracotomies, three thoracoabdominal resections, and multiple asynchronous procedures in six patients). Results: Thirty-eight of 48 patients (79%) were rendered grossly free of disease and 29 (60%) obtained a serologic remission. Ten patients (21%) remain continuously disease-free with no postoperative treatment with a median follow-up of 46 months (range, 31 to 89). Six additional patients who relapsed after salvage surgery are currently disease-free with further treatment (four with repeat surgery and two with high-dose chemotherapy and autologous bone marrow transplantation [ABMT]). Conclusion: Selected patients with chemorefractory but resectable germ cell tumors have definite potential for cure with salvage surgery.

Original languageEnglish
Pages (from-to)324-329
Number of pages6
JournalJournal of Clinical Oncology
Volume11
Issue number2
StatePublished - 1993

Fingerprint

Germ Cell and Embryonal Neoplasms
Drug Therapy
Autologous Transplantation
Thoracotomy
Lymph Node Excision
Bone Marrow Transplantation
Reoperation
Cisplatin
Therapeutics
Biomarkers

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Murphy, B. R., Breeden, E. S., Donohue, J. P., Messemer, J., Walsh, W., Roth, B. J., & Einhorn, L. (1993). Surgical salvage of chemorefractory germ cell tumors. Journal of Clinical Oncology, 11(2), 324-329.

Surgical salvage of chemorefractory germ cell tumors. / Murphy, Brian R.; Breeden, Elyse S.; Donohue, John P.; Messemer, Jon; Walsh, William; Roth, Bruce J.; Einhorn, Lawrence.

In: Journal of Clinical Oncology, Vol. 11, No. 2, 1993, p. 324-329.

Research output: Contribution to journalArticle

Murphy, BR, Breeden, ES, Donohue, JP, Messemer, J, Walsh, W, Roth, BJ & Einhorn, L 1993, 'Surgical salvage of chemorefractory germ cell tumors', Journal of Clinical Oncology, vol. 11, no. 2, pp. 324-329.
Murphy BR, Breeden ES, Donohue JP, Messemer J, Walsh W, Roth BJ et al. Surgical salvage of chemorefractory germ cell tumors. Journal of Clinical Oncology. 1993;11(2):324-329.
Murphy, Brian R. ; Breeden, Elyse S. ; Donohue, John P. ; Messemer, Jon ; Walsh, William ; Roth, Bruce J. ; Einhorn, Lawrence. / Surgical salvage of chemorefractory germ cell tumors. In: Journal of Clinical Oncology. 1993 ; Vol. 11, No. 2. pp. 324-329.
@article{3dbe1725b022472dacaec3f0aeb780bc,
title = "Surgical salvage of chemorefractory germ cell tumors",
abstract = "Purpose: Patients with disseminated germ cell tumors who relapse after salvage chemotherapy, or who progress during cisplatin-based therapy, have chemorefractory disease and a very poor prognosis. A subset of these patients will have chemorefractory but resectable disease. We have therefore evaluated the role of salvage surgery in this patient population. Patients and Methods: We performed a retrospective review of all patients with disseminated germ cell tumors who were felt to have chemorefractory disease and underwent salvage surgery from 1977 to 1990 at Indiana University. All patients had elevated serum markers or other signs of progressive carcinoma. A total of 48 patients underwent surgery (33 retroperitoneal lymph node dissections [RPLNDs], six thoracotomies, three thoracoabdominal resections, and multiple asynchronous procedures in six patients). Results: Thirty-eight of 48 patients (79{\%}) were rendered grossly free of disease and 29 (60{\%}) obtained a serologic remission. Ten patients (21{\%}) remain continuously disease-free with no postoperative treatment with a median follow-up of 46 months (range, 31 to 89). Six additional patients who relapsed after salvage surgery are currently disease-free with further treatment (four with repeat surgery and two with high-dose chemotherapy and autologous bone marrow transplantation [ABMT]). Conclusion: Selected patients with chemorefractory but resectable germ cell tumors have definite potential for cure with salvage surgery.",
author = "Murphy, {Brian R.} and Breeden, {Elyse S.} and Donohue, {John P.} and Jon Messemer and William Walsh and Roth, {Bruce J.} and Lawrence Einhorn",
year = "1993",
language = "English",
volume = "11",
pages = "324--329",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "2",

}

TY - JOUR

T1 - Surgical salvage of chemorefractory germ cell tumors

AU - Murphy, Brian R.

AU - Breeden, Elyse S.

AU - Donohue, John P.

AU - Messemer, Jon

AU - Walsh, William

AU - Roth, Bruce J.

AU - Einhorn, Lawrence

PY - 1993

Y1 - 1993

N2 - Purpose: Patients with disseminated germ cell tumors who relapse after salvage chemotherapy, or who progress during cisplatin-based therapy, have chemorefractory disease and a very poor prognosis. A subset of these patients will have chemorefractory but resectable disease. We have therefore evaluated the role of salvage surgery in this patient population. Patients and Methods: We performed a retrospective review of all patients with disseminated germ cell tumors who were felt to have chemorefractory disease and underwent salvage surgery from 1977 to 1990 at Indiana University. All patients had elevated serum markers or other signs of progressive carcinoma. A total of 48 patients underwent surgery (33 retroperitoneal lymph node dissections [RPLNDs], six thoracotomies, three thoracoabdominal resections, and multiple asynchronous procedures in six patients). Results: Thirty-eight of 48 patients (79%) were rendered grossly free of disease and 29 (60%) obtained a serologic remission. Ten patients (21%) remain continuously disease-free with no postoperative treatment with a median follow-up of 46 months (range, 31 to 89). Six additional patients who relapsed after salvage surgery are currently disease-free with further treatment (four with repeat surgery and two with high-dose chemotherapy and autologous bone marrow transplantation [ABMT]). Conclusion: Selected patients with chemorefractory but resectable germ cell tumors have definite potential for cure with salvage surgery.

AB - Purpose: Patients with disseminated germ cell tumors who relapse after salvage chemotherapy, or who progress during cisplatin-based therapy, have chemorefractory disease and a very poor prognosis. A subset of these patients will have chemorefractory but resectable disease. We have therefore evaluated the role of salvage surgery in this patient population. Patients and Methods: We performed a retrospective review of all patients with disseminated germ cell tumors who were felt to have chemorefractory disease and underwent salvage surgery from 1977 to 1990 at Indiana University. All patients had elevated serum markers or other signs of progressive carcinoma. A total of 48 patients underwent surgery (33 retroperitoneal lymph node dissections [RPLNDs], six thoracotomies, three thoracoabdominal resections, and multiple asynchronous procedures in six patients). Results: Thirty-eight of 48 patients (79%) were rendered grossly free of disease and 29 (60%) obtained a serologic remission. Ten patients (21%) remain continuously disease-free with no postoperative treatment with a median follow-up of 46 months (range, 31 to 89). Six additional patients who relapsed after salvage surgery are currently disease-free with further treatment (four with repeat surgery and two with high-dose chemotherapy and autologous bone marrow transplantation [ABMT]). Conclusion: Selected patients with chemorefractory but resectable germ cell tumors have definite potential for cure with salvage surgery.

UR - http://www.scopus.com/inward/record.url?scp=0027462641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027462641&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 324

EP - 329

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 2

ER -